Listen here on your chosen podcast platform.
A new lung cancer vaccine has been tested on a UK patient for the first time.
BNT116 is designed to treat non-small cell lung cancer – also known as NSCLC – the most common form of the disease.
Professor Siow Ming Lee, consultant medical oncologist at University College London Hospitals NHS Foundation Trust, and chief investigator for the trial in the UK, tells Tech & Science Daily how it works, and why this could be game changing for lung cancer patients around the globe.
The phase one clinical trial is the first in human study of BNT116, which will be given to lung cancer patients alongside standard immunotherapy.
67-year-old Janusz Racz, who lives in London, is the first person to have the vaccine in the UK.
He was diagnosed with lung cancer in May and soon after, started chemotherapy and radiotherapy, which was given simultaneously.
The trial will take place across 34 research sites in seven countries, with six located in England and Wales.
Overall, it’s hoped about 130 lung cancer patients will be enrolled, 20 of whom will be based in the UK.
If you’re in London docklands this weekend, then you might see a 2.5-ton block of ice suspended from a crane.
Joshua Thomson from Australian physical theatre company Legs On The Wall, discusses their new performance THAW by and why they hope to highlight the impact of climate change.
The performance is on at the Greenwich + Docklands International Festival.
And the rest
SpaceX reveals the date for the first ever commercial spacewalk attempt, an Iceland volcano erupts again with huge plumes of lava visible from Reykjavik, and a terrifying dinosaur is discovered with very ‘distinctive eyebrows’.
You can listen to the episode in the player above, find us on Apple, Spotify, or wherever you get your podcasts.
